BDBM386161 (2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(4-fluoro-3- (6,7,8,9-tetrahydro- 5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenyl) pyrrolidine- 2-carboxamide::US10287301, Compound 92::US10822352, Comp No. 92

SMILES CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(cc12)-c1ccnnc1

InChI Key InChIKey=OJSCJYOQHSYERH-DJUQAAIZSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 386161   

TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM386161((2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-ind...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM386161((2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-ind...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration was incubated with test compound at various conc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent